126 related articles for article (PubMed ID: 36916439)
1. STAT3 signaling in prostate cancer progression and therapy resistance: An oncogenic pathway with diverse functions.
Sadrkhanloo M; Paskeh MDA; Hashemi M; Raesi R; Motahhary M; Saghari S; Sharifi L; Bokaie S; Mirzaei S; Entezari M; Aref AR; Salimimoghadam S; Rashidi M; Taheriazam A; Hushmandi K
Biomed Pharmacother; 2023 Feb; 158():114168. PubMed ID: 36916439
[TBL] [Abstract][Full Text] [Related]
2. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
[TBL] [Abstract][Full Text] [Related]
3. LDL cholesterol promotes the proliferation of prostate and pancreatic cancer cells by activating the STAT3 pathway.
Jung YY; Ko JH; Um JY; Chinnathambi A; Alharbi SA; Sethi G; Ahn KS
J Cell Physiol; 2021 Jul; 236(7):5253-5264. PubMed ID: 33368314
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of constitutively active Stat3 reverses enzalutamide resistance in LNCaP derivative prostate cancer cells.
Liu C; Zhu Y; Lou W; Cui Y; Evans CP; Gao AC
Prostate; 2014 Feb; 74(2):201-9. PubMed ID: 24307657
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of STAT3 signaling targets both tumor-initiating and differentiated cell populations in prostate cancer.
Han Z; Wang X; Ma L; Chen L; Xiao M; Huang L; Cao Y; Bai J; Ma D; Zhou J; Hong Z
Oncotarget; 2014 Sep; 5(18):8416-28. PubMed ID: 25261365
[TBL] [Abstract][Full Text] [Related]
6. RNA interference targeting Stat3 inhibits growth and induces apoptosis of human prostate cancer cells.
Lee SO; Lou W; Qureshi KM; Mehraein-Ghomi F; Trump DL; Gao AC
Prostate; 2004 Sep; 60(4):303-9. PubMed ID: 15264241
[TBL] [Abstract][Full Text] [Related]
7. Dual relationship between long non-coding RNAs and STAT3 signaling in different cancers: New insight to proliferation and metastasis.
Ashrafizadeh M; Gholami MH; Mirzaei S; Zabolian A; Haddadi A; Farahani MV; Kashani SH; Hushmandi K; Najafi M; Zarrabi A; Ahn KS; Khan H
Life Sci; 2021 Apr; 270():119006. PubMed ID: 33421521
[TBL] [Abstract][Full Text] [Related]
8. Capsazepine inhibits JAK/STAT3 signaling, tumor growth, and cell survival in prostate cancer.
Lee JH; Kim C; Baek SH; Ko JH; Lee SG; Yang WM; Um JY; Sethi G; Ahn KS
Oncotarget; 2017 Mar; 8(11):17700-17711. PubMed ID: 27458171
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA HEGBC promotes tumorigenesis and metastasis of gallbladder cancer via forming a positive feedback loop with IL-11/STAT3 signaling pathway.
Yang L; Gao Q; Wu X; Feng F; Xu K
J Exp Clin Cancer Res; 2018 Aug; 37(1):186. PubMed ID: 30086773
[TBL] [Abstract][Full Text] [Related]
10. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.
Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G
Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267
[TBL] [Abstract][Full Text] [Related]
11. STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response.
Sadrkhanloo M; Entezari M; Orouei S; Ghollasi M; Fathi N; Rezaei S; Hejazi ES; Kakavand A; Saebfar H; Hashemi M; Goharrizi MASB; Salimimoghadam S; Rashidi M; Taheriazam A; Samarghandian S
Pharmacol Res; 2022 Aug; 182():106311. PubMed ID: 35716914
[TBL] [Abstract][Full Text] [Related]
12. T40214/PEI complex: a potent therapeutics for prostate cancer that targets STAT3 signaling.
Weerasinghe P; Li Y; Guan Y; Zhang R; Tweardy DJ; Jing N
Prostate; 2008 Sep; 68(13):1430-42. PubMed ID: 18615483
[TBL] [Abstract][Full Text] [Related]
13. Nimbolide-Induced Oxidative Stress Abrogates STAT3 Signaling Cascade and Inhibits Tumor Growth in Transgenic Adenocarcinoma of Mouse Prostate Model.
Zhang J; Ahn KS; Kim C; Shanmugam MK; Siveen KS; Arfuso F; Samym RP; Deivasigamanim A; Lim LH; Wang L; Goh BC; Kumar AP; Hui KM; Sethi G
Antioxid Redox Signal; 2016 Apr; 24(11):575-89. PubMed ID: 26649526
[TBL] [Abstract][Full Text] [Related]
14. Heteronemin Is a Novel c-Met/STAT3 Inhibitor Against Advanced Prostate Cancer Cells.
Wu JC; Wang CT; Hung HC; Wu WJ; Wu DC; Chang MC; Sung PJ; Chou YW; Wen ZH; Tai MH
Prostate; 2016 Dec; 76(16):1469-1483. PubMed ID: 27416770
[TBL] [Abstract][Full Text] [Related]
15. EC-70124, a Novel Glycosylated Indolocarbazole Multikinase Inhibitor, Reverts Tumorigenic and Stem Cell Properties in Prostate Cancer by Inhibiting STAT3 and NF-κB.
Civenni G; Longoni N; Costales P; Dallavalle C; García Inclán C; Albino D; Nuñez LE; Morís F; Carbone GM; Catapano CV
Mol Cancer Ther; 2016 May; 15(5):806-18. PubMed ID: 26826115
[TBL] [Abstract][Full Text] [Related]
16. Oncostatin M induces tumorigenic properties in non-transformed human prostate epithelial cells, in part through activation of signal transducer and activator of transcription 3 (STAT3).
Sterbova S; Karlsson T; Persson E
Biochem Biophys Res Commun; 2018 Apr; 498(4):769-774. PubMed ID: 29526757
[TBL] [Abstract][Full Text] [Related]
17. Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition.
Liu C; Lou W; Armstrong C; Zhu Y; Evans CP; Gao AC
Prostate; 2015 Sep; 75(13):1341-53. PubMed ID: 25970160
[TBL] [Abstract][Full Text] [Related]
18. Penta-1,2,3,4,6-O-galloyl-beta-D-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo.
Hu H; Lee HJ; Jiang C; Zhang J; Wang L; Zhao Y; Xiang Q; Lee EO; Kim SH; Lü J
Mol Cancer Ther; 2008 Sep; 7(9):2681-91. PubMed ID: 18790750
[TBL] [Abstract][Full Text] [Related]
19. Metformin inhibits castration-induced EMT in prostate cancer by repressing COX2/PGE2/STAT3 axis.
Tong D; Liu Q; Liu G; Xu J; Lan W; Jiang Y; Xiao H; Zhang D; Jiang J
Cancer Lett; 2017 Mar; 389():23-32. PubMed ID: 28043910
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of STAT3/PD-L1 and Activation of miR193a-5p Are Critically Involved in Apoptotic Effect of Compound K in Prostate Cancer Cells.
Lee JH; Lee DY; Lee HJ; Im E; Sim DY; Park JE; Park WY; Shim BS; Kim SH
Cells; 2021 Aug; 10(8):. PubMed ID: 34440920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]